| Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome | DG62 | | |
| Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices | DG61 | | |
| Digital technologies for assessing attention deficit hyperactivity disorder (ADHD) | DG60 | | |
| CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack | DG59 | | |
| Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer | DG58 | | |
| Artificial intelligence (AI)-derived software to help clinical decision making in stroke | DG57 | | |
| Devices for remote monitoring of Parkinson's disease | DG51 | | |
| Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care | DG56 | | |
| AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images | DG55 | | |
| FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care | DG48 | | |
| Transperineal biopsy for diagnosing prostate cancer | DG54 | | |
| Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers | DG52 | | |
| MRI fusion biopsy systems for diagnosing prostate cancer | DG53 | | |
| MRI-based technologies for assessing non-alcoholic fatty liver disease | DG50 | | |
| PLGF-based testing to help diagnose suspected preterm pre-eclampsia | DG49 | | |
| Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment) | DG47 | | |
| PredictSURE IBD and IBDX to guide treatment of Crohn's disease | DG45 | | |
| EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules | DG46 | | |
| SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea | DG44 | | |
| QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography | DG43 | | |
| Testing strategies for Lynch syndrome in people with endometrial cancer | DG42 | | |
| Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke | DG41 | | |
| High-sensitivity troponin tests for the early rule out of NSTEMI | DG40 | | |
| Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test) | DG39 | | |
| SepsiTest assay for rapidly identifying bloodstream bacteria and fungi | DG20 | | |
| Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast | DG37 | | |
| Rapid tests for group A streptococcal infections in people with a sore throat | DG38 | | |
| Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis | DG36 | | |
| Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care | DG35 | | |
| Biomarker tests to help diagnose preterm labour in women with intact membranes | DG33 | | |
| Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I | DG32 | | |
| Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) | DG14 | | |
| Tests in secondary care to identify people at high risk of ovarian cancer | DG31 | | |
| New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners | DG3 | | |
| Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis | DG29 | | |
| Virtual chromoendoscopy to assess colorectal polyps during colonoscopy | DG28 | | |
| Molecular testing strategies for Lynch syndrome in people with colorectal cancer | DG27 | | |
| High-throughput non-invasive prenatal testing for fetal RHD genotype | DG25 | | |
| ImmunoCAP ISAC 112 for multiplex allergen testing | DG24 | | |
| Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits) | DG22 | | |
| VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions | DG19 | | |
| Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) | DG18 | | |
| Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment | DG16 | | |
| Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems) | DG13 | | |
| Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel | DG11 | | |
| EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer | DG9 | | |
| Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer | DG8 | | |
| Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M | DG6 | | |
| SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver | DG5 | | |
| The EOS 2D/3D imaging system | DG1 | | |